Skip to main content
. Author manuscript; available in PMC: 2019 Jun 17.
Published in final edited form as: J Am Coll Health. 2017 May 8;65(6):380–388. doi: 10.1080/07448481.2017.1312418

Table 2.

Number of persons answering “yes” on questionnaire administered prior to dose 1 to screen participants for potential contraindications or precautions to receiving MenB-4C vaccine.

Question University A
n (%)
University B
n (%)
Combined
n (%)
Are you aware of any severe reaction to any vaccine you have previously received that required medical attention? 36 (0.50%) 36 (0.37%) 72 (0.42%)
Do you have a known sensitivity to latex? 39 (0.55%) 77 (0.78%) 116 (0.68%)
Do you have a known allergy to kanamycin? (Kanamycin is an antibiotic similar to neomycin and streptomycin.) 4 (0.06%) 4 (0.04%) 8 (0.05%)
Do you have any known serious or chronic medical problems that we should be aware of? 420 (5.9%) 726 (7.38%) 1,146 (6.75%)
Are you older than 50 years? 6 (0.08%) 2 (0.02%) 8 (0.05%)
Are you pregnant or think you could be pregnant? 0 (0%) 2 (0.02%) 2(0.01%)
Are you breastfeeding? 0 (0%) 0 (0%) (0%)
Have you ever fainted or passed out after getting a vaccine, receiving an injection, or having your blood drawn?A n/a 500 (5.08%) n/a

Note.

A

This question was not included on the written questionnaire at University A and no data was collected for the verbal fainting history screening conducted there.